Repurposing FDA-approved drugs and natural compounds to inhibit the RNA-dependent RNA polymerase domain of dengue virus 2 or dengue virus 3
Crossref DOI link: https://doi.org/10.1038/s41598-025-96284-0
Published Online: 2025-04-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ahmadi, Khadijeh
Jahantigh, Hamid Reza
Ahmadi, Nahid
Shahbazi, Behzad
Text and Data Mining valid from 2025-04-12
Version of Record valid from 2025-04-12
Article History
Received: 4 December 2024
Accepted: 27 March 2025
First Online: 12 April 2025
Declarations
:
: The authors declare no competing interests.